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Abstract
 
Given the broad expression of H-2 class Ib molecules on hematopoietic cells, antigen presenta-
tion pathways among CD1d expressing cells might tightly regulate CD1d-restricted natural
killer T (NKT) cells. Bone marrow–derived dendritic cells (BM-DCs) and not adherent sple-
nocytes become capable of triggering NK1.1
 
 
 
/T cell receptor (TCR)
 
int
 
 hepatic NKT cell acti-
vation when (a) immature BM-DCs lack H-2D
 
b
 
 
 
/
 
 
 
 molecules or (b) BM-DCs undergo a stress
signal of activation. In such conditions, BM-DCs promote T helper type 1 predominant
CD1d-restricted NKT cell stimulation. H-2 class Ia–mediated inhibition involves more the di-
rect H-2D
 
b
 
 presentation than the indirect Qa-1
 
b
 
 pathway. Such inhibition can be overruled by
B7/CD28 interactions and marginally by CD40/CD40L or interleukin 12. These data point to
a unique regulatory role of DCs in NKT cell innate immune responses and suggest that H-2
class Ia and Ib pathways differentially control NKT cell recognition of DC antigens.
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 • costimulation • CD1d • NKT cells
 
Introduction
 
NKT cells are a recently described subpopulation of
TCR
 
 
 
/
 
 
 
 
 
CD4
 
 
 
 or CD4
 
 
 
CD8
 
 
 
 T cells that have distinc-
tive phenotypic and functional properties (1, 2). These T
cells were first identified in mice, where they can be distin-
guished from conventional T cells by their expression of
the NK locus-encoded C type lectin molecule NK1.1. An-
other hallmark of murine NKT cells is their extremely re-
stricted TCR repertoire, with the great majority expressing
an invariant TCR
 
 
 
 chain structure (V
 
 
 
14-J
 
 
 
281) paired
preferentially with V
 
 
 
8, 7, or 2. Both mouse and human
NKT cells rapidly secrete cytokines associated with both
Th1 (IFN-
 
 
 
) or Th2 (IL-4) responses upon TCR engage-
ment (1, 2) or stimulation with the synthetic CD1d ligand,
the 
 
 
 
-Galactosylceramide (
 
 
 
-GalCer) (3–5).
Recent results suggest a major role for murine NKT cells
in the rejection of malignant tumors (6–10) and in regulat-
ing autoimmunity (11) and defense against certain patho-
gens. Indeed, NKT cells were shown to be relevant in in-
nate antitumor immunosurveillance after IL-12 (6, 9) or
 
 
 
-GalCer administration (10, 12) but also in spontaneous,
endogenous IL-12–dependent tumor models in mice (8).
Cytokines play an important part at the NKT cell effector
phase (8, 12). However, several conditions exist in which
the apparent Th0 profile of cytokine production may be
skewed toward a predominance of IFN-
 
 
 
 (11, 12) or IL-4
(13, 14) and IL-13 (15) leading to immunosuppression.
The origin and identity of the natural antigens recog-
nized by CD1d-restricted T cells remain unknown. Given
the canonical 
 
 
 
 chains and limited 
 
 
 
 chain diversity of the
TCR of NKT cells, mCD1d may recognize a single or
conserved set of antigens. Whether CD1d binding sphin-
golipid or phospholipid compounds represent self or for-
eign antigens (16), and whether the NKT cells responding
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to the synthetic 
 
 
 
-GalCer are the same as those seeing
phospholipids is unclear. However, mCD1d-restricted T
cells varied in their recognition of different mCD1d trans-
fected tumor cells suggesting that antigens presented by
mCD1d molecules differ according to the cell type (17,
18). Variations in CD1d-restricted antigen presentation
could arise from differences in expression, trafficking, pro-
cessing, or loading of antigens (19).
As dendritic cells (DCs) are cornerstones between innate
(20) and cognate immune responses, we investigated the
regulatory mechanisms underlying the DC/NKT cell
cross-talk in vitro. Our data imply that potent H-2D
 
b
 
–
mediated inhibition constitutively prevents DC-mediated
IFN-
 
 
 
 production from resting NKT cells. The direct
H-2D molecular pathway is partially involved in H-2 class
I–mediated inhibition. However, after stress-induced matura-
tion, DCs become electively capable of triggering CD1d-
restricted NKT cells toward a Th1 predominant pattern in
a B7/CD28-dependent manner, thereby overcoming H-2
class I–mediated inhibitory pathways. Our results provide
further evidence for the pivotal role of DCs in NKT cell
immune responses and identify DCs as a potential source of
endogenous CD1d-restricted antigens.
 
Materials and Methods
 
Mice.
 
Female C57BL/6 (H-2
 
b
 
) mice were obtained from the
Centre d’ Elevage Janvier (Le Genest St Isle, France), the Centre
d’ Elevage Iffa Credo (L’Arbresle, France), and maintained in our
animal facilities according to the Animal Experimental Ethics
Committee Guidelines. Single H-2K
 
b
 
 
 
/
 
 
 
 and H-2D
 
b
 
 
 
/
 
 
 
 and
double H-2K
 
b
 
 
 
/
 
 
 
D
 
b
 
 
 
/
 
 
 
 knockout (KO) mice as well as triple
 
 
 
2microglobulin
 
 
 
/
 
 
 
H-2K
 
b
 
 
 
/
 
 
 
D
 
b
 
 
 
/
 
 
 
 KO mice were generated as
described previously (21), bred in the animal facility of Institut
Pasteur, and used at the sixth backcross generation onto C57BL/6
mice. CD1d
 
 
 
/
 
  
 
single and CD1d
 
 
 
/
 
 
 
H-2K
 
b
 
 
 
/
 
 
 
D
 
b
 
 
 
/
 
 
 
 triple KO
mice were generated as described previously (22), bred at Prince-
ton Animal Facility or Pasteur Institute, and used at the seventh
backcross generation onto C57BL/6 mice. All female mice were
used at 6–25 wk of age.
 
Purification of Hepatic NKT Cells and T Cells.
 
Hepatic NKT
cells (defined as NK1.1
 
 
 
TCR-
 
 
 
int
 
 cells) and T cells (NK1.1
 
 
 
TCR-
 
 
 
high
 
 cells) were prepared as described previously (23, 24).
Briefly, hepatic mononuclear cells were stained with FITC-con-
jugated TCR
 
 
 
 (H57–597; BD PharMingen) and PE-conjugated
NK1.1 (PK-136; BD PharMingen) and sorted by FACSVan-
tage™ (Becton Dickinson). Purity of sorted cells exceeded 95%
(data not shown). After overnight culture in complete medium,
NKT cells could be restained using the anti-CD94 mAb coupled
to PE (BD PharMingen).
 
Generation of DCs.
 
Bone marrow (BM)-derived DCs (BM-
DCs) were propagated from BM progenitor cells in culture me-
dium supplemented with 1,000 IU/ml of rmGM-CSF (R&D
Systems) and 1,000 IU/ml of rmIL-4 (R&D Systems) as de-
scribed previously (20). Culture medium was renewed at day 2
and 4. To induce stress and maturation of DCs, day 6 DCs were
harvested, spun down, and transferred into new 6-well plates
(referred to as “transferred” henceforth). For phenotypic analy-
ses, cells were preincubated with culture supernatant of hybrid-
oma (2.4G2) secreting anti-CD16/CD32 mAb, and were sub-
sequently incubated with FITC-conjugated anti–I-A
 
b
 
 (AF6–
120.1) and PE-conjugated anti-CD11c (HL-3), FITC-conju-
gated CD80 (16–10A1), CD86 (GL1), CD40 (3/23) or PE-con-
jugated CD1d (1B1) or the anti-H2D
 
b
 
 (B22.249.R19; from
H. Lemke, Institüt Für Genetik, Köln, Germany) or anti–
H-2K
 
b
 
 (AF6–88.5.3 from American Type Culture Collection
[HB-158]) mAb. All antibodies except 2.4G2 were purchased
from BD PharMingen. Cells were gated according to size and
granulosity with exclusion of PI-positive cells. Residual B lym-
phocytes (B220
 
 
 
 cells) and granulocytes (Gr1
 
 
 
 cells) were de-
tected in the CD11c
 
 
 
/I-A
 
b
 
 
 
 cells and constitute 
 
 
 
20% of
whole cell population. T and NK cells were not propagated in
these DC culture conditions. BM-DCs derived from gene tar-
geted mice were analyzed for MHC class Ia and Ib expression
and exhibited levels of MHC class II, CD80, CD86, CD40 ex-
pression comparable to those of wild-type (wt) BM-DCs (see
Fig. 1, and data not shown). Splenic adherent cells were gener-
ated by subjecting red blood cell deprived splenocytes to 3 h ad-
herence at 37
 
 
 
C. Adherent cells were rinsed three times with
PBS, incubated with 10 mM EDTA for 20 min, and analyzed in
FACScan™ for CD11c, MHC class II, CD1d, CD40, CD80, or
CD86 expression.
 
In Vitro Cocultures.
 
The hepatic NK1.1
 
 
 
TCR-
 
 
 
int
 
 NKT
cells or NK1.1
 
 
 
TCR-
 
 
 
high
 
 T cells (5 
 
 
 
 10
 
4
 
) were cocultured
with immature or mature BM-DCs (2 
 
 
 
 10
 
3
 
–10
 
4
 
–5 
 
 
 
 10
 
4
 
) in
200 
 
 
 
l of complete medium in 96-well U-bottomed plates for
24–44 h at 37
 
 
 
C, 5% CO
 
2
 
. As positive controls, DCs were
pulsed with 10 ng/ml of 
 
 
 
-GalCer (provided by Pharmaceutical
Research Laboratories, KIRIN Brewery Co., Gunma, Japan),
washed in PBS, and cocultured with NKT cells. For blocking
experiments, BM-DCs and NKT cells were cocultured in the
presence of 50 
 
 
 
g/ml of neutralizing anti-CD40L mAb (MR;
BD PharMingen), 50 
 
 
 
g/ml of CTLA-4 Ig fusion protein (gift
from the Genetics Institute, Cambridge, MA), 25 
 
 
 
g/ml of
anti–IL-12 mAb (C17.8; BD PharMingen), and of isotype-
matched rat or hamster mAb (BD PharMingen). To mimic the
stimulatory effects of B7 on mature DCs, we incubated imma-
ture day 6 BM-DCs with NKT cells along with 10 or 50 
 
 
 
g/ml
of stimulating anti-CD28 mAb PV.1 (provided by C. June, Uni-
versity of Pennsylvania, Philadelphia, PA) plus or minus 100 IU
rhIL-2/ml. To investigate the inhibitory pathways, immature
DCs derived from wt mice were incubated with neutralizing
anti-H2D
 
b
 
 (B22.249.R19; from H. Lemke, Köln, Germany) or
anti–H-2K
 
b
 
 (AF6–88.5.3 from American Type Culture Collec-
tion [HB-158]) mAb and immature DCs derived from D
 
b
 
 
 
/
 
 
 
mice were incubated with increasing dosages (1–5-10 
 
 
 
M) of
Qdm1 (Qa-1
 
b
 
 binding peptide i.e. AMAPRTLLL) or R5K
(mock Qa-1
 
b
 
 binding peptide i.e. AMVPKTLLL provided by
D. Raulet, University of Berkeley, Berkeley, CA) peptides for
24 h at 37
 
 
 
C. The Qa-1
 
b
 
 mAb (clone 6A8.6F10.1A6) was pur-
chased from BD PharMingen. All coculture conditions were
performed in duplicates and experiments performed at least
three times.
 
Cytokine Detection and Quantification (mIFN
 
 
 
 and mIL-4).
 
Af-
ter 20–44 h DC/NKT or T coculture, supernatants were har-
vested, stored at 
 
 
 
80
 
 
 
C, and assessed either directly or after 5–50
times dilution using commercial ELISA kits (OptEIATM ELISA
kit; BD PharMingen). The sensitivity of the mIFN
 
 
 
 kit was
 
 
 
31.5 pg/ml and that of mIL-4 kit was 
 
 7.15 pg/ml.
Statistical Analyses of Cytokine Levels. Fisher’s exact method
was used to compare means   SE of IFN-  production in-
between various culture conditions and significant differences at
95% confidence are depicted with * on each graph.1181 Ikarashi et al. Brief Definitive Report
Results and Discussion
Constitutive Inhibition of the DC/NKT Cell Cross-Talk.
We first investigated the capacity of ex vivo propagated
BM-DCs at an immature stage of differentiation to trigger
cytokine secretion from resting hepatic NK1.1 /TCRint
NKT cells in vitro. After 6 d of in vitro culture in GM-
CSF plus IL-4, 50–55% BM cells became CD11c /MHC
class II , expressed CD1d, and a small fraction was MHC
class IIbright and expressed CD80, CD86, and CD40 mole-
cules (“non transferred DC (day6),” Fig. 1). Such imma-
ture DCs, when cocultured with liver NKT cells at various
DC/NKT cell ratios, did not induce NKT cell triggering
as already reported (3, 12, 23; Fig. 2, a–c). Similar data
were achieved using immature DCs propagated in GM-
CSF alone or DCs sorted from spleens of Flt3L-treated
mice (data not shown). As reported previously (23), when
immature CD1d  DCs were pulsed with  -GalCer (1–10
ng/ml), high levels of IFN-  (Fig. 3 a) and IL-4 (not
shown) were measured in the supernatants of DC/NKT
cell cocultures.
However, when derived from H-2Db / Kb /  class I
gene–targeted mice, immature DCs became capable of
triggering IFN-  secretion at nanogramm levels from he-
patic NKT cells in a dose-dependent manner (Fig. 2 a). In
contrast, low levels of IL-4 (100–300 pg/ml) were detected
in the supernatants of NKT cells cocultured with H-2Db / 
Kb /  gene-targeted BM-DCs (not shown). However,
such nanogram levels of IFN-  secretion were not found
using BM-DCs propagated from H-2Db / Kb / 
 2microglobulin /  triple KO mice instead of Db / Kb / 
double KO mice (Fig. 2 a) suggesting that the constitutive
Figure 1. Phenotypic analyses of ex vivo propagated BM-
DCs. BM-DCs (GM-CSF plus IL-4) at day 6 (wt, left panels,
and H-2Db / , right panels) before/or at day 7 after harvest-
ing and transfer into new wells (wt, middle panels) were sub-
jected to two color staining (CD11c-PE and I-Ab-FITC) or
one-color staining (CD1d-PE and CD40, CD80, CD86-
FITC, indirect staining for H-2Db and H-2Kb expression) and
immunostained cells were analyzed in flow cytometry.1182 Regulation of the DC/NKT Cell Cross-Talk
DC/NKT cell cross-talk involves  2microglobulin-associ-
ated H-2 class Ib molecules.
The DC/NKT Cell Cross-Talk Is Dependent on CD1d
Molecules. We formally demonstrated that CD1d play a
dominant role in the constitutive DC/NKT cell cross-talk
by comparing IFN-  levels secreted by NKT cells in co-
culture with BM-DCs derived from H-2Db / Kb / 
CD1d /  versus H-2Db / Kb /  mice originating from
similar backcrosses in B6 mice (Fig. 2 b). DCs were elec-
tively endowed with the constitutive capacity to present
CD1d-restricted antigens since CD1d /CD86 /I-Ab  ad-
herent splenocytes did not promote IFN-  secretion from
NKT cells even when derived from H-2Db / Kb / mice
(Fig. 2 b).
Direct Role of H-2D Molecules in the Constitutive Inhibition
of the DC/NKT Cell Cross-Talk. It has been shown that
NKT cell maturation is accompanied by extinction of Ly49
receptor expression. Liver NKT cells, as opposed to thy-
mus NKT cells, are mature NKT cells and do not express
Ly-49A, Ly-49C/I, or Ly-49-G (25). However, Skold and
Cardell (26) pointed out the differential regulation of Ly49
expression on CD4  and double negative NK1.1  T cells
with dramatic organ specific variations, stressing the com-
plexity of NKT cell inhibitory pathways. Importantly, we
were able to exclude a role for the H-2Kb/Ly49C pathway
in the constitutive DC/NKT cell inhibition and to show a
dominant inhibitory role of H-2Db molecules at early time
points of the DC/NKT cell interaction (Fig. 2 c, left
panel). Searching for the H-2 Db–specific inhibitory ligand,
one should consider the possibility that H-2Db recognition
could be direct and/or indirect. Indirect recognition is pos-
sible via the ubiquitously expressed Qa-1b molecules which
preferentially associate with a H-2Db leader peptide
(Qdm), this peptide representing  70% of those eluted
from Qa-1 molecules (27, 28). A CD94-NKG2A NKT
cell inhibition would not rule out the coexistence of an ad-
ditional inhibitory receptor interacting directly with H-2Db
molecules. Therefore, we assessed the role of these inhibi-
tory pathways by either (a) pulsing Qa-1b binding peptides
(i.e. Qdm1 AMAPRTLLL or the mock peptides R5K
Figure 2. Constitutive H-2D–mediated NKT cell inhibition by immature DCs. (a) Day 6 immature BM-DCs derived from B6.wt or H-2Kb / Db / 
double KO or H-2Kb / Db /  2m / triple KO mice were cocultured at a DC/NKT cell ratio of 1:1 or 1:25 with cell sorted hepatic NK1.1 /TCRint
NKT cells for 40 h. (b) Similar experiments were performed comparing BM-DCs with adherent splenocytes derived from B6. wt versus H-2Kb / Db / 
double KO versus CD1d /  Kb /  Db /  triple KO mice cocultured with NKT cells at a DC/NKT cell ratio of 1:1 for 40 h. (c) Similar experiments
were performed comparing immature day 6 BM-DCs derived from single (H-2Kb /  or H-2Db / ) KO mice versus H-2 Kb / Db /  double KO mice
(left panels). 24 and 40 h supernatants were assayed for IFN-  in ELISA. Right panel depicts IFN-  levels in the supernatants of NKT cells with day 6 wt
BM-DCs incubated with increasing amounts of neutralizing Ab anti–H-2Db or H-2Kb. Means   SE are depicted in all graphs. Each graph represents ei-
ther pooled data from three experiments performed in duplicate wells or a representative experiment out of three. Significant differences at 95% confi-
dence using Fisher’s exact method are outlined with *. All experiments were performed with KO female mice of 6–8 wk of age after 6–8 backcrosses on
C57BL/6 mice. Phenotypic features were comparable in all gene targeted BM-DCs except for H-2 or CD1d molecule expression.1183 Ikarashi et al. Brief Definitive Report
(AMVPKTLLL) that does not bind Qa-1) at increasing
dosages on H-2Db/  BM-DC, (b) or using the neutralizing
mAb anti–H-2Db or anti–H-2Kb pulsed onto wt day 6
BM-DCs before NKT cell coculture. Only 20–25% of he-
patic NKT cells (TCR int/NK1.1 ) express CD94 mole-
cules (among which not all coexpress NKG2A molecules)
i.e. up to 4% of bulk liver mononuclear cells (not shown).
The amounts of IFN-  secreted from NKT cells in cocul-
Figure 3. Stress triggers DC maturation, promoting CD1d-restricted, B7-dependent NKT cell
activation. (a) Day 6 immature BM-DCs pulsed or not pulsed with 10 ng/ml of  -GalCer were
compared with mature day 7 BM-DCs in a coculture setting with hepatic NKT cells or T cells at
a DC/NKT or T cell ratio of 1:5 for 40 h. (b) Cocultures of day 7 transferred DCs derived from
B6.wt versus CD1d /  mice with hepatic NK1.1  TCR- int NKT cells or hepatic NK1.1 
TCR- high T cells at various DC/NKT ratios were assayed for mIFN-  (left panels) and at DC/
NKT cell ratio of 1:5 for mIL-4 (right panel) using ELISA for 40 h. (c) Day 7 mature DCs were
cocultured with NKT cells at a DC/NKT cell ratio of 1:5 for 24 h in the presence of 50  g/ml of
neutralizing mAb directed against mIL-12 (C17.8), mCD40L (MR1), or isotype-matched Ab or
CTLA4Ig fusion proteins (left panel). Day 6 wt BM-DC were coincubated with NKT cells at a
1:5 ratio with increasing dosages of the stimulating anti-CD28 Ab PV1 plus or minus 100 IU/ml
rhuIL-2 (right panel) for 48 h. Supernatants were assayed for IFN-  in ELISA. Means   SE are
depicted in all graphs. Each graph depicts one representative experiment out of three performed
in duplicate wells. Significant differences at 95% confidence using Fisher’s exact method are out-
lined with *.1184 Regulation of the DC/NKT Cell Cross-Talk
ture with day 6 immature wt versus H-2Db /  BM-DCs
incubated with increasing dosages of Qa-1b binding pep-
tides were compared (1–30  M of Qdm1 or R5K mock
peptides). No significant inhibition of IFN-  production
was observed using Qdm1 peptides pulsed onto H-2Db / 
BM-DCs (not shown). In accordance with this result, the
neutralizing anti–Qa-1b mAb did not allow IFN-  produc-
tion by NKT cells cocultured with wt day 6 BM-DCs (not
shown). The right panel of Fig. 2 c investigates the direct
inhibitory pathway and compares the secretion levels of
IFN-  by NKT cells stimulated by wt day 6 BM-DCs in-
cubated with 10 to 50  g/ml of neutralizing anti–H-2Db / 
or anti–H-2Kb /  Ab. Significant IFN-  secretion is found
only using the anti–H-2Db /  Ab, although nanogram lev-
els were achieved using mature DCs (not shown on this
graph). Therefore, in line with the well known heteroge-
neity of the NKT cell population, a complex inhibitory
pathway likely participates in maintaining DC-mediated
tolerance of liver resident NKT cells.
These data imply that H-2 class Ia and Ib molecules dif-
ferentially and constitutively prevent DC-mediated IFN- 
production from resting liver NKT cells and that CD1d-
restricted antigens are presented electively by DC to NKT
cells in vitro.
Stressed DCs Become Capable of Stimulating NKT Cells.
However, in stress conditions shown to be mimicked by
cell harvest and transfer into new plastic dishes (29) or by
LPS, wt DCs became activated and acquired a more mature
phenotype i.e. MHC class IIbright, CD80 , CD86 , and
CD40  (“transferred” day 7 DCs, Fig. 1) displaying potent
allostimulatory capacity (not shown) while CD1d was not
significantly overexpressed (Fig. 1). Moreover, the expres-
sion levels of the H-2K and H-2D molecules were compa-
rable at day 7 (Fig. 1). After their transfer at day 6, day 7 wt
DCs acquired the capacity to foster NKT cells toward a
Th1 predominant secretion pattern while pulsing with
KRN7000 in such conditions led to secretion of both IL-4
and IFN-  at high levels (not shown). High levels of IFN- 
were measured in 22–40 h coculture supernatants (Fig. 3 a)
while IL-4 was barely detectable (Fig. 3 b). Mature DCs
stimulated NKT cells in a dose-dependent manner (Fig. 3
b), with optimal effects at a ratio of 1 DC:1 NKT cell (Fig.
3 b). Similar NKT cell activation was obtained using LPS-
activated DCs (not shown). No significant thymidine in-
corporation by NKT cells was measured in proliferation as-
says and trypan blue exclusion did not show increased
numbers of viable NKT cells after 40 h incubation with
mature DCs (not shown). The mature DC/NKT cell
cross-talk was significantly inhibited when DCs were gen-
erated from B6.CD1d /  mice (Fig. 3 b). Inhibition was
also clear for IL-4 secretion (Fig. 3 b). The phenotype of
mature DCs in B6 wt and B6.CD1d /  mice was compa-
rable (not shown). Eberl et al. (30) pointed out a tissue-spe-
cific segregation of CD1d-dependent and -independent
NKT cells, hepatic NKT cells being mostly CD1d depen-
dent. In similar conditions of B6 liver cell sorting, CD3 /
NK1.1  hepatic T cells also produce, albeit less efficiently,
detectable amounts of IFN-  (but no IL-4) when placed in
close contact with mature DCs. It is noteworthy that, in
contrast to NKT cell activation, T cell activation was not
regulated by CD1d molecules nor  -GalCer (Fig. 3 b). It is
unlikely that IFN-  is secreted from DCs rather than NKT
cells in these cocultures as only CD8  DCs were shown to
produce IFN-  after stimulation with ng levels of both IL-
12 and IL-18 (31).
The DC maturation allowed to overcome H-2 class Ia–
mediated constitutive NKT cell inhibition by DCs, as
comparable levels of IFN-  were secreted by NKT cells in
contact with wt versus Kb / Db /  mature DCs (data not
shown). However, the synthetic  -GalCer–mediated
Figure 4. Putative schematic
representation of the DC/NKT
cell cross-talk. Tissue resident
DCs (immature stage) constitu-
tively inhibit CD1d-dependent
NKT cell IFN-  production
(first signal: CD1d/TCR)
through a mechanism involving
H-2 class I molecules (second
signal: H-2D/Ly49?  / 
CD94/NKG2A ?). The inhibi-
tory pathway might be domi-
nant because a third accessory
pathway overruling the domi-
nant negative signal is lacking
on immature DCs. In contrast,
after stress (LPS, transfer), DCs
acquire a third accessory signal
(B7/CD28) that is dominant
over the second inhibitory path-
way allowing CD1d-restricted
DC antigen presentation. It is
conceivable that in pathological
conditions where high IFN-  levels are required, DCs become capable of triggering NKT cell recognition of self and/or foreign antigens presented
by MHC class Ib molecules to the canonical TCR.1185 Ikarashi et al. Brief Definitive Report
CD1d stimulation was more potent, even at low dosage
(1–10 ng/ml) than the self DC antigens and Th0 biased.
The low levels of CD1d-dependent IL-4 secretion by
NKT cells triggered by mature DCs could be accounted
for by the relative weakness of the CD1d-mediated presen-
tation of DC self-antigens (Fig. 3, a and b) and/or discrete
threshold of reactivity of various hepatic NKT cell subsets.
The B7/CD28 Pathway Overrides the H-2Db-mediated
NKT Cell Inhibition. We next investigated the mecha-
nisms accounting for NKT cell IFN-  secretion after con-
tact with stressed DCs. During  -GalCer–mediated NKT
cell stimulation, IL-12 and CD40 were shown to play a
critical role (3, 12). However, despite the Th1 predomi-
nant pattern, IL-12 p70 was not detectable in ELISA in
NKT cell cocultures with mature DCs where significant
IFN-  levels were measured (not shown). However, as
neutralizing anti–IL-12 mAb decreased IFN-  secretion,
albeit not significantly (mostly at early time points 24 h of
the coculture), it remains conceivable that IL-12 be in-
volved after the initial CD1d/TCR interaction step (Fig. 3
c, left panel). Moreover, in transwell experiments whereby
mature DCs and NKT cells are physically separated by a
porous membrane, IFN-  was not produced suggesting a
dominant role for a membrane-associated molecule in the
DC/NKT cell cross-talk (data not shown). Therefore, we
next investigated whether costimulatory molecules upregu-
lated upon maturation could account for circumvention of
H-2 class I–mediated inhibition. Saturating concentrations
of neutralizing mAb directed against CD40L or B7 mole-
cules were used in the DC/NKT cell cocultures. While a
partial but not significant inhibition was observed using
neutralizing anti-CD40L mAb, CTLA4Ig fusion proteins
were shown to be necessary and sufficient to completely
abrogate the DC/NKT cell cross-talk in vitro. Both, NKT
cell IFN-  (Fig. 3 c, left panel) and IL-4 secretion (not
shown) were suppressed. To confirm that CD28 engage-
ment is sufficient to trigger hepatic NKT cell IFN-  pro-
duction by DCs, wt BM-DCs at day 6 (immature cells)
were cocultured with hepatic NKT cells in the presence of
stimulating anti-CD28 mAb (PV.1) with or without low
doses of IL-2 (100 IU/ml). H-2 class I–mediated inhibition
could be efficiently overcome using the anti-CD28 mAb
plus IL-2 with a synergistic effects between the cytokine
and the costimulatory factor (Fig. 3 c, right panel). The
IFN-  levels were fairly comparable with those achieved
using mature BM-DCs (day7). Altogether, the B7/CD28
pathway is critical to account for the ability of activated
DCs to trigger NKT cell IFN-  production by circum-
venting class I inhibition.
A Schematic View of the DC/NKT Cell Cross-Talk In
Vitro. These data demonstrate that stress-induced DC ac-
tivation allows to overcome constitutive inhibitory pathways
through B7/CD28 interaction, thereby promoting CD1d-
dependent IFN-  production by NKT cells in vitro (Fig.
4). The role of CD1d and B7 expression levels, of DC en-
dogenous antigens and/or tissue origin need to be investi-
gated to ascribe these regulatory NKT activation pathways
to BM-DCs. We showed that DCs and not adherent sple-
nocytes (antigen-presenting cells expressing high levels of
CD1d molecules, and low levels of I-Ab, B7.2 molecules),
when devoid of inhibitory receptor ligand, trigger NKT
cell activation. Such a difference may be accounted for by
tissue origin. Indeed, while activated BM-DCs could trig-
ger IFN-  production, Flt3L splenic DCs after overnight
activation were not able to activate NKT cells (not shown).
It is also possible that B7.1 is critical to overcome H-2 class
I–mediated inhibition because adherent splenocytes do not
express B7.1. Intracellular trafficking of CD1d molecules
may play a critical role in determining the antigens pre-
sented by DCs.
It is noteworthy that DC-mediated NKT cell activation
is leading predominantly to Th1 secretion pattern in vitro,
suggesting that this regulatory pathway may be relevant in
the setting of intracellular pathogens, viruses, or tumors.
IFN-  is a pleiotropic cytokine playing a central role in
promoting innate and adaptive mechanisms of host defense.
IFN-  not only fosters T cell–mediated immunity but also
activates macrophages, promotes antigen processing, and
presentation by antigen-presenting cell and prevents viral
replication, angiogenesis, and transformed cell growth (32).
Therefore, it is conceivable that dysregulation of DC func-
tions suggested in autoimmune disorders or tumors might
foster NKT cell reactivity toward inappropriate Th pattern.
Further investigations will be required to unravel the in
vivo dynamics between DCs and NKT cells during infec-
tion, autoimmunity, or tumor development but such data
outline that CD1d-restricted DC antigens might be rele-
vant in such disorders.
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